ClearPoint Neuro Reports First Quarter 2023 Results
May 11, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
May 10, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
April 28, 2023 16:42 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System
April 20, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
April 18, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
April 13, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil
April 13, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro,...
ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS
April 11, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt
March 28, 2023 17:57 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die...
ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale
March 28, 2023 17:57 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et...